Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 Myeloproliferative Disease 10 Mins Read2 iFrame is not supported! Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 By John Mascarenhas, MD What is the…
Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 Myeloproliferative Disease 10 Mins Read19 Pacritinib: Phase 3 PACIFICA Trial Dr. Mascarenhas ASH 2022 By John Mascarenhas, MD What is the study of Pacritinib in…
T-DXd Interstitial Lung Disease: Controllable Adverse Event? Lung 12 Mins Read0 Is Interstitial Lung Disease a Manageable Adverse Event of Trastuzumab T-DXd Deruxtecan Treatment? What is Trastuzumab T-DXd? Trastuzumab T-DXd is…
